Last, it could be helpful to assess the extent of host cellular responses, such as markers of local or systemic levels of immune regulatory cells affected by TGF-β, desmoplasia as well as tumor hypoxia, as they could help devise an optimal therapeutic strategy. This evidence concerns the gene TGFB1 and neoplasm.